Tolemy Bio is a Cambridge and Barcelona-based biotech startup building the virtual-cell intelligence layer for modern biopharma. Founded in 2024 by Alex Ward and Caelan Anderson, the company’s platform, Orbit, combines experimental data, agentic AI and virtual-cell models to help advanced therapy and biologics teams make their cell biology more predictable, interpretable and controllable.
Tolemy Bio
- Life Sciences
- Cambridge, United Kingdom
- £1.2m
- tolemy.bio
- Update Information
More venture news
- 18 Sept 2026
Big Picture BioBig Picture Bio raises a £1.5m pre-seed round led by Kadmos Capital and Exceptional Ventures to design cancer combination therapies
Pre-seedLife Sciences - 16 Sept 2026
Eterna RegenerativesEterna Regeneratives closes a seed round led by Hoxton Ventures and The Venture Collective to develop keratin-based enamel repair
SeedLife Sciences - 15 Sept 2026
Magnitude BiosciencesMagnitude Biosciences raises £1.3m led by Northstar Ventures to run drug discovery screens in living nematode worms
EquityLife Sciences
